A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a ...

Encouraging Preclinical Data: Decoy20 has produced efficacy in preclinical studies across a variety of tumor types and in combination with four different classes of existing drugs, demonstrating both ...